(RTTNews) - scPharmaceuticals Inc. (SCPH) Monday reported positive topline results from the pharmacokinetic study of SCP-111 (furosemide), administered via an autoinjector. The study compared the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback